| Risk | High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 2.74% |
| NAV | ₹8.7 (20 May 2019) |
|---|---|
| Fund Started | 28 Dec 2015 |
| Fund Size | ₹180 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 14.8% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 10.1% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 9.9% |
| Piramal Enterprises Ltd. | Healthcare | Equity | 9.7% |
| Syngene International Ltd. | Healthcare | Equity | 7.7% |
| Dishman Carbogen Amcis Ltd. | Healthcare | Equity | 6.7% |
| Alembic Pharmaceuticals Ltd. | Healthcare | Equity | 4.6% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.5% |
| Cadila Healthcare Ltd. | Healthcare | Equity | 4.3% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 3.6% |
Tata Mutual Fund started their mutual fund on 30/06/1995 and its managing total assets of ₹44,897 Cr. Its ranked at 13 as per total assets at end of 30th Sep 2017.
Tata is one of the most trusted brands in India and has been successful in every field it has ventured to. Tata Mutual fund is known for its world-class service across the country and it has made a mark in the minds of investors.
It offers funds across various categories like, equity, debt, hybrid and sectoral. The motto of this AMC is to propel investing among the retail investors irrespective of their risk appetite, ideal investment duration, profession, salary or gender.
They believe in following a value-based investment methodology which enables them to attain consistent results over the years. They also believe in flexibility, by offering a large variety of funds across various market capitalization. Stability and integrity is one of the main pillar of business for Tata Mutual Fund and they believe in keeping an investor's money in the best possible hands.